Article

Segment 5 - Future Directions

In the final segment of the panel discussion, each panel member gave their final thoughts on the discussion topic.

In the final segment of the panel discussion, each panel member gave their final thoughts on the subject at hand. “For the healthcare resources that we have, it’s important for us to start targeting those healthcare dollars towards care that actually makes a difference and improves the health of our patients and the family members,” said Ms Larsen-Haidle. Dr Brawley stated that genetic testing is a complicated area that needs to stay with the experts. Counselors are crucial with the influx of genetic testing today. Counselors, providers, and patients need to work together in order to effectively manage patients.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
David Awad, PharmD, BCOP
Coral Omene, MD, PhD, sitting for a vieo interview
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Coral Omene, MD, PhD, sitting for a vieo interview
David Awad, PharmD, BCOP
Screenshot of Coral Omene, MD, PhD
ASCO 2025
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Cathy Eng, MD, FACP, FASCO
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo